The AIBS Public Policy Office has released its annual report for 2025. Read about our achievements in science policy.

A coalition of 122 organizations, including AIBS, has sent a letter to House and Senate appropriators requesting at least $1.7 billion for the Advanced Research Projects Agency for Health in fiscal year 2027.

AIBS has joined four other partner organizations in releasing a statement in response to the decision by the Federal Judiciary Center to remove the climate science chapter from the Reference Manual on Scientific Evidence.

AIBS joined 27 other organizations in submitting comments to the Federal Communications Commission on a company's proposal to deploy solar-reflecting satellites into space to sell sunlight at night.

AIBS has signed on to three community letters supporting increased fiscal year (FY) 2027 funding for research programs at the U.S. Department of Agriculture.

AIBS joined 65 other organizations in a letter requesting at least $7.15 billion for the National Institute of Allergy and Infectious Diseases and at least $51.303 billion for the National Institutes of Health in FY 2027.

AIBS has endorsed bipartisan legislation that recognizes biological data as a strategic national resource and aims to leverage the vast biodiversity of U.S. public lands to drive scientific and economic innovation.

AIBS joined 64 other organizations in urging the Department of Health and Human Services to reconvene the President’s Advisory Council on Combatting Antibiotic Resistance (PACCARB) as soon as possible.

AIBS has endorsed a joint society letter to President Trump expressing strong support for the National Center for Atmospheric Research (NCAR).

In response to recent policy changes on the US childhood immunization schedule, AIBS joined 70 other scientific and medical organizations in a letter urging federal public health leaders to reaffirm their commitment to a transparent, evidence-based immunization policy process.

In response to a request for information from the White House Office of Science and Technology Policy, AIBS has provided comments emphasizing the need for sustained and predictable federal investments to accelerate the American scientific enterprise.